Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline Transcript
Source: SeekingAlpha
2026-03-09 18:47:57 ET
Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline March 9, 2026 12:00 PM EDT...
Read the full article on Seeking Alpha
For further details see:
Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline Transcript
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
2.32% G/L:
$54.153 Last:
345,099 Volume:
$54.18 Open:
RHHBY Latest News
March 09, 2026 02:10:00 am
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
